Quarterly report [Sections 13 or 15(d)]

Other current assets (Details)

v3.25.2
Other current assets (Details) - USD ($)
$ in Thousands
Jul. 04, 2025
Jun. 30, 2025
Dec. 31, 2024
Other current assets      
Research and development credits receivable   $ 18,277 $ 12,929
Prepayments   8,232 10,033
Clinical materials     59
VAT receivable   1,305 1,599
Other current assets   3,516 3,170
Total   $ 31,330 $ 27,790
Research & Development Tax Credits      
Other current assets      
Amount of receivable from Research and Development credits $ 14,200